Management of tubal ectopic pregnancy with methotrexate in the setting of symptomatic Coronavirus disease 2019 (COVID-19): A case report
Methotrexate, ectopic pregnancy, coronavirus
Published online: Sep 24 2021
Background: Coronavirus Disease 2019 (COVID-19) represents a complex therapeutic challenge. As the pandemic progresses, patients are presenting with ectopic pregnancies (EPs) and symptomatic COVID-19.
Objective: We present the management of a patient with multiple medical comorbidities and tubal EP in the setting of severe symptomatic COVID-19 infection where all management options were precluded.
Methods: Case report with literature review of management of tubal EP in the setting of severe symptomatic COVID-19 infection.
Result: After careful consideration of options, the patient underwent successful medical management with methotrexate while receiving supportive care for COVID-19.
Conclusions: Methotrexate proved to be the safest therapeutic option in this patient. Management of patients with severe COVID-19 and gynaecologic emergencies should be individualised and carefully reviewed with evolving knowledge of COVID-19.